ISSN: 2161-0681

Журнал клинической и экспериментальной патологии

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Индексировано в
  • Индекс Коперника
  • Google Scholar
  • Шерпа Ромео
  • Открыть J-ворота
  • Генамика ЖурналSeek
  • ЖурналТОС
  • Справочник периодических изданий Ульриха
  • РефСик
  • Университет Хамдарда
  • ЭБСКО, Аризона
  • OCLC- WorldCat
  • Публикации
  • Женевский фонд медицинского образования и исследований
  • Евро Паб
  • ICMJE
Поделиться этой страницей

Абстрактный

Performance of Laboratory Methods for Detection of Polymyxin-Resistance in Gram-Negative Bacillus

Eliana Carolina Vespero*, Gerusa Luciana Gomes Magalhae, Marsileni Pelisson, Rayane Alves dos Santos, Joice Lopes Siqueira, Julia da Silva Pimenta, Tiago Danelli, Joao Gabriel Material Soncini, Ariane Tiemy Tizura, Daniela Frizon Alfieri and Marcia Regina Eches Perugini

Resistance to polymyxin, mediated by chromosomal mutations and plasmid-borne mcr genes, is increasingly being reported not only in clinical bacteria but also in animals, farms, foods, and the environment. In this study, we evaluated a test capable of detecting resistance to polymyxins during antimicrobial susceptibility testing by the agar dilution test. We evaluated 521 consecutive isolates from A. baumannii, P. aeruginosa and Enterobacteriaceae and 57 polymyxin-resistant K. pneumoniae. We performed tests by the agar dilution method for colistin and polymyxin B (colispot and polyspot, respectively), the Broth Micro Dilution (BMD) method, and the VITEK ® 2 automated system for colistin. The colispot and polyspot tests were evaluated in concentrations of 2.0, 4.0 and 8.0 μg/mL. Considering BMD as a reference method, 420 isolates were shown to be colistin sensitive, 158 isolates were colistin resistant, 423 isolates were sensitive to polymyxin B and 155 isolates were resistant to polymyxin B. The AUC of the ROC curve showed better performance for 4.0 μg/mL, with values of 0.9671 and 0.9568 for colispot and polyspot, respectively. The Kappa index was 0.9305 for colispot and 0.9079 for polyspot. All isolates analyzed by VITEK ® 2 exhibited ROC curves with AUC values of 0.9541 and a Kappa index of 0.9049. Colispot and polyspot at a concentration of 4.0 μg/mL had higher results than the VITEK ® 2 system. The results showed that colispot and polyspot can be used with confidence in the practice of clinical laboratories.